Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Price:
5.29 USD
1.54%
Market Closed
Updated:
May 29, 2024
Aurinia Pharmaceuticals Inc
Total Liabilities & Equity
|
Aurinia Pharmaceuticals Inc
Total Liabilities & Equity Peer Comparison
Comparables:
ZYME
TH
RPTX
FUSN
EDT
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Total Liabilities & Equity
$516.6m
|
CAGR 3-Years
7%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Total Liabilities & Equity
$580.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Theratechnologies Inc
TSX:TH
|
Total Liabilities & Equity
$72.1m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
14%
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Total Liabilities & Equity
$253.9m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
79%
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Total Liabilities & Equity
$285.8m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
56%
|
CAGR 10-Years
N/A
|
|
|
Spectral Medical Inc
TSX:EDT
|
Total Liabilities & Equity
CA$4.9m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-2%
|
See Also
What is Aurinia Pharmaceuticals Inc's Total Liabilities & Equity?
Total Liabilities & Equity
516.6m
USD
516.6m
USD
Based on the financial report for Mar 31, 2024, Aurinia Pharmaceuticals Inc's Total Liabilities & Equity amounts to 516.6m USD.
What is Aurinia Pharmaceuticals Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
23%
23%
Over the last year, the Total Liabilities & Equity growth was 14%. The average annual Total Liabilities & Equity growth rates for Aurinia Pharmaceuticals Inc have been 7% over the past three years , 26% over the past five years , and 23% over the past ten years .
You don't have any saved screeners yet
